Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval "In the first quarter of 2025, we achieved a major milestone for Aquestive with the submission ...

Screen time is a hot topic among parents. With children spending more time in front of screens than ever before, it’s natural ...